XH001

BIOLOGICAL2 trials

Sponsors

Wu Wenming, Peking Union Medical College Hospital

Conditions

Pancreatic Cancer

Unknown Phase

XH001 Combination With Immunocheckpoint Inhibitor and Chemotherapy for Patients With Resected Pancreatic Cancer

RecruitingNCT06353646

Wu WenmingPancreatic Cancer

Start: 2024-03-12End: 2026-12-01Target: 28Updated: 2026-02-13

XH001 (New Antigen Tumor Vaccine) Combined With Chemotherapy as Adjuvant Therapy in Pancreatic Cancer

Not yet recruitingNCT07114666

Peking Union Medical College HospitalPancreatic Cancer

Start: 2025-08-18End: 2030-08-31Target: 12Updated: 2025-08-11